Embree Financial Group Boosts Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Embree Financial Group increased its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 64.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 83,212 shares of the company’s stock after purchasing an additional 32,500 shares during the quarter. Ryan Specialty accounts for 0.9% of Embree Financial Group’s portfolio, making the stock its 23rd largest position. Embree Financial Group’s holdings in Ryan Specialty were worth $5,339,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the company. Exchange Traded Concepts LLC grew its stake in Ryan Specialty by 2.6% during the 4th quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company’s stock valued at $755,000 after purchasing an additional 295 shares in the last quarter. Avior Wealth Management LLC grew its position in shares of Ryan Specialty by 2,113.3% during the fourth quarter. Avior Wealth Management LLC now owns 3,497 shares of the company’s stock worth $224,000 after buying an additional 3,339 shares in the last quarter. Janney Montgomery Scott LLC increased its stake in shares of Ryan Specialty by 4.9% in the fourth quarter. Janney Montgomery Scott LLC now owns 17,825 shares of the company’s stock worth $1,144,000 after buying an additional 831 shares during the last quarter. SG Americas Securities LLC raised its holdings in Ryan Specialty by 94.2% in the fourth quarter. SG Americas Securities LLC now owns 3,253 shares of the company’s stock valued at $209,000 after acquiring an additional 1,578 shares in the last quarter. Finally, UMB Bank n.a. boosted its stake in Ryan Specialty by 5.7% during the 4th quarter. UMB Bank n.a. now owns 5,522 shares of the company’s stock valued at $354,000 after acquiring an additional 298 shares during the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on RYAN shares. Morgan Stanley began coverage on Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price for the company. Wells Fargo & Company lowered their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 14th. Bank of America raised their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. Barclays increased their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Finally, The Goldman Sachs Group lifted their target price on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $74.40.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the completion of the sale, the executive vice president now owns 12,386 shares in the company, valued at $884,236.54. This represents a 54.42 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director David P. Bolger sold 7,055 shares of the company’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total transaction of $500,058.40. Following the completion of the transaction, the director now directly owns 78,149 shares in the company, valued at $5,539,201.12. This trade represents a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,887 shares of company stock valued at $18,118,273 over the last quarter. Company insiders own 11.10% of the company’s stock.

Ryan Specialty Stock Down 1.5 %

NYSE RYAN opened at $63.27 on Friday. The company has a market capitalization of $16.57 billion, a P/E ratio of 82.16, a PEG ratio of 1.14 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a 12 month low of $42.21 and a 12 month high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company’s 50 day simple moving average is $67.34 and its 200 day simple moving average is $66.21.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.41. The business had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company’s quarterly revenue was up 20.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.32 EPS. Equities research analysts expect that Ryan Specialty Holdings, Inc. will post 1.82 earnings per share for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were issued a $0.11 dividend. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.70%. Ryan Specialty’s payout ratio is currently 57.14%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.